BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30931897)

  • 1. Denosumab: A potential new treatment option for recurrent Aneurysmal Bone Cyst of the spine.
    Kulkarni AG; Patel A
    SICOT J; 2019; 5():10. PubMed ID: 30931897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of Aneurysmal Bone Cyst to Denosumab.
    Skubitz KM; Peltola JC; Santos ER; Cheng EY
    Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
    Dubory A; Missenard G; Domont J; Court C
    Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management and Denosumab for Aneurysmal Bone Cysts of the Spine in an Australian Tertiary Paediatric Centre.
    Vanderniet JA; Tsinas D; Wall CL; Girgis CM; London K; Keane C; Briody J; Hibbert S; Poon M; Padhye B; Biggin A; Dalla-Pozza L; Gray RJ; Munns CF
    Calcif Tissue Int; 2023 May; 112(5):592-602. PubMed ID: 36810677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denosumab: a potential treatment option for aneurysmal bone cyst of the atlas.
    Patel RS; Dhamne CA; Gopinathan A; Kumar N; Kumar N
    Eur Spine J; 2018 Jul; 27(Suppl 3):494-500. PubMed ID: 29470716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
    Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of Recurrent Aggressive Aneurysmal Bone Cyst of Distal Tibia to Denosumab Treatment.
    Ahmed HA; Almasoudi EA; Nail LL; Samargandi R
    J Orthop Case Rep; 2024 Jun; 14(6):157-162. PubMed ID: 38910984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.
    Lange T; Stehling C; Fröhlich B; Klingenhöfer M; Kunkel P; Schneppenheim R; Escherich G; Gosheger G; Hardes J; Jürgens H; Schulte TL
    Eur Spine J; 2013 Jun; 22(6):1417-22. PubMed ID: 23455951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neoadjuvant denosumab in the treatment of aneurysmal bone cysts: a case series and review of the literature.
    Giantini-Larsen AM; Chakravarthy VB; Barzilai O; Newman WC; Wexler L; Bilsky MH
    J Neurosurg Pediatr; 2022 Dec; 30(6):547-554. PubMed ID: 36282899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneurysmal bone cyst: A review of 65 patients.
    Grahneis F; Klein A; Baur-Melnyk A; Knösel T; Birkenmaier C; Jansson V; Dürr HR
    J Bone Oncol; 2019 Oct; 18():100255. PubMed ID: 31463187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneurysmal bone cyst: results of an off label treatment with Denosumab.
    Dürr HR; Grahneis F; Baur-Melnyk A; Knösel T; Birkenmaier C; Jansson V; Klein A
    BMC Musculoskelet Disord; 2019 Oct; 20(1):456. PubMed ID: 31630689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab Therapy in the Management of Aneurysmal Bone Cysts: A Comprehensive Literature Review.
    Alhumaid I; Abu-Zaid A
    Cureus; 2019 Jan; 11(1):e3989. PubMed ID: 30972268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab and sclerotherapy for recurrent spinal aneurysmal bone cyst in a child.
    Singh R; Madasswery S; Colman M; Kent PM
    BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38589235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Management of a Substantial Pelvic Aneurysmatic Bone Cyst Including the Off-Label Use of Denosumab in a 35-Year-Old Female Patient.
    Ntalos D; Priemel M; Schlickewei C; Thiesen DM; Rueger JM; Spiro AS
    Case Rep Orthop; 2017; 2017():9125493. PubMed ID: 29181213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneurysmal bone cyst of the spine in adult patients: A systematic review and comparison of primary vs secondary lesions.
    Palmisciano P; Hunter M; Lokesh N; Bin Alamer O; Scalia G; Giammalva GR; Maugeri R; Iacopino DG; Umana GE; Haider AS
    J Clin Neurosci; 2022 Jun; 100():15-22. PubMed ID: 35367732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab in the management of Aneurysmal bone cyst.
    Maximen J; Robin F; Tronchot A; Rossetti A; Ropars M; Guggenbuhl P
    Joint Bone Spine; 2022 Jan; 89(1):105260. PubMed ID: 34481945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
    Palmerini E; Ruggieri P; Angelini A; Boriani S; Campanacci D; Milano GM; Cesari M; Paioli A; Longhi A; Abate ME; Scoccianti G; Terzi S; Trovarelli G; Franchi A; Picci P; Ferrari S; Leopardi MP; Pierini M
    Tumori; 2018 Oct; 104(5):344-351. PubMed ID: 30086700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Management of Aggressive Recurrent Aneurysmal Bone Cyst of Spine: Case Report and Review of Literature.
    Frassanito P; D'Onofrio GF; Pennisi G; Massimi L; Tamburrini G; Muto M; Caldarelli M
    World Neurosurg; 2019 Jun; 126():423-427. PubMed ID: 30904804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Denosumab in Treating Spinal Aneurysmal Bone Cyst: A Case Report.
    Kotaka S; Fujiwara Y; Ota R; Manabe H; Adachi N
    Cureus; 2023 Jun; 15(6):e39954. PubMed ID: 37415990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.